Buy Or Sell Opportunity • May 21
Now 27% undervalued The stock has been flat over the last 90 days, currently trading at CN¥32.57. The fair value is estimated to be CN¥44.50, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Xuhui Wen was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Duyuru • Apr 30
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 20, 2026, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China Duyuru • Mar 30
Macmic Science&Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 30, 2026 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 30, 2026 Duyuru • Dec 26
Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 30, 2026 Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 30, 2026 Duyuru • Sep 30
Macmic Science&Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 31, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 31, 2025 Duyuru • Jun 30
Macmic Science&Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 29, 2025 Duyuru • Apr 15
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 09, 2025, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China Duyuru • Mar 28
Macmic Science&Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Duyuru • Dec 27
Macmic Science&Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025 Macmic Science&Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025 Duyuru • Dec 06
Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares. Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 30.12 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into shares. If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 12 months. Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.007 (vs CN¥0.11 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.007 (down from CN¥0.11 in 3Q 2023). Revenue: CN¥343.1m (down 7.5% from 3Q 2023). Net income: CN¥1.53m (down 93% from 3Q 2023). Profit margin: 0.4% (down from 6.2% in 3Q 2023). Revenue is forecast to grow 29% p.a. on average during the next 3 years, compared to a 23% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Oct 15
Investor sentiment deteriorates as stock falls 18% After last week's 18% share price decline to CN¥17.40, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 52% over the past year. Duyuru • Sep 30
Macmic Science&Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to CN¥14.80, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 27x in the Semiconductor industry in China. Total loss to shareholders of 61% over the past year. New Risk • Sep 14
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 25% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (2.5x net interest cover). Minor Risks Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (4.1% net profit margin). Reported Earnings • Aug 23
Second quarter 2024 earnings released: EPS: CN¥0.023 (vs CN¥0.15 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.023 (down from CN¥0.15 in 2Q 2023). Revenue: CN¥390.2m (down 9.9% from 2Q 2023). Net income: CN¥4.23m (down 87% from 2Q 2023). Profit margin: 1.1% (down from 7.3% in 2Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 26% p.a. on average during the next 3 years, compared to a 22% growth forecast for the Semiconductor industry in China. New Risk • Jul 23
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.3% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). High level of non-cash earnings (25% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Profit margins are more than 30% lower than last year (5.9% net profit margin). Duyuru • Jun 28
Macmic Science&Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 23, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 23, 2024 Valuation Update With 7 Day Price Move • Jun 13
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to CN¥24.77, the stock trades at a forward P/E ratio of 24x. Average forward P/E is 31x in the Semiconductor industry in China. Total loss to shareholders of 60% over the past year. Reported Earnings • Apr 27
First quarter 2024 earnings released: CN¥0.01 loss per share (vs CN¥0.20 profit in 1Q 2023) First quarter 2024 results: CN¥0.01 loss per share (down from CN¥0.20 profit in 1Q 2023). Revenue: CN¥246.4m (down 26% from 1Q 2023). Net loss: CN¥1.72m (down 106% from profit in 1Q 2023). Revenue is forecast to grow 44% p.a. on average during the next 2 years, compared to a 23% growth forecast for the Semiconductor industry in China. Duyuru • Apr 27
Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024 Macmic Science&Technology Co.,Ltd., Annual General Meeting, May 24, 2024, at 14:00 China Standard Time. Location: The Company's Meeting Room, Changzhou, Jiangsu China Buy Or Sell Opportunity • Apr 20
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 31% to CN¥25.01. The fair value is estimated to be CN¥31.53, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 50% over the last 3 years. Earnings per share has grown by 27%. Revenue is forecast to grow by 115% in 2 years. Earnings are forecast to grow by 204% in the next 2 years. Duyuru • Mar 30
Macmic Science&Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Macmic Science&Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Valuation Update With 7 Day Price Move • Mar 27
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥28.11, the stock trades at a forward P/E ratio of 17x. Average forward P/E is 32x in the Semiconductor industry in China. Total loss to shareholders of 62% over the past year. Simply Wall St's valuation model estimates the intrinsic value at CN¥31.79 per share. Duyuru • Mar 01
Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces an Equity Buyback for CNY 50 million worth of its shares. Macmic Science&Technology Co.,Ltd. (SHSE:688711) announces a share repurchase program. Under the program, the company will repurchase up to CNY 50 million worth of its shares. The shares will be repurchased at no more than CNY 46.99 per share. The purpose of the program is to use the repurchased shares for equity incentives or employee stock ownership plans or for converting corporate bonds issued by listed companies that can be converted into . If the company fails to use the shares for said purposes within 3 years of completion of the program, the unused or not transferred shares will be cancelled. The program will be funded from company's own funds. The plan will be valid for 6 months. Reported Earnings • Feb 24
Full year 2023 earnings released: EPS: CN¥0.76 (vs CN¥0.52 in FY 2022) Full year 2023 results: EPS: CN¥0.76 (up from CN¥0.52 in FY 2022). Revenue: CN¥1.51b (up 63% from FY 2022). Net income: CN¥114.8m (up 46% from FY 2022). Profit margin: 7.6% (down from 8.5% in FY 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥29.34, the stock trades at a forward P/E ratio of 19x. Average forward P/E is 25x in the Semiconductor industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥51.16 per share. Valuation Update With 7 Day Price Move • Dec 06
Investor sentiment deteriorates as stock falls 15% After last week's 15% share price decline to CN¥40.84, the stock trades at a forward P/E ratio of 27x. Average forward P/E is 34x in the Semiconductor industry in China. Simply Wall St's valuation model estimates the intrinsic value at CN¥53.31 per share. Buying Opportunity • Dec 04
Now 24% undervalued after recent price drop Over the last 90 days, the stock is down 24%. The fair value is estimated to be CN¥53.45, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 52% over the last 3 years. Earnings per share has grown by 29%. Revenue is forecast to grow by 107% in 2 years. Earnings is forecast to grow by 202% in the next 2 years. New Risk • Nov 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (36% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (6.7% average weekly change). Profit margins are more than 30% lower than last year (7.1% net profit margin). Reported Earnings • Oct 27
Third quarter 2023 earnings released: EPS: CN¥0.15 (vs CN¥0.19 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.15 (down from CN¥0.19 in 3Q 2022). Revenue: CN¥371.0m (up 32% from 3Q 2022). Net income: CN¥23.0m (down 21% from 3Q 2022). Profit margin: 6.2% (down from 10% in 3Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 25% growth forecast for the Semiconductor industry in China. Reported Earnings • Aug 18
Second quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.13 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.21 (up from CN¥0.13 in 2Q 2022). Revenue: CN¥433.3m (up 125% from 2Q 2022). Net income: CN¥31.6m (up 59% from 2Q 2022). Profit margin: 7.3% (down from 10% in 2Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 32% p.a. on average during the next 3 years, compared to a 24% growth forecast for the Semiconductor industry in China. Duyuru • Jun 28
Macmic Science&Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 18, 2023 Macmic Science&Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 18, 2023 Reported Earnings • Apr 26
First quarter 2023 earnings released: EPS: CN¥0.22 (vs CN¥0.086 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.22 (up from CN¥0.086 in 1Q 2022). Revenue: CN¥331.2m (up 137% from 1Q 2022). Net income: CN¥30.9m (up 152% from 1Q 2022). Profit margin: 9.3% (up from 8.8% in 1Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 36% p.a. on average during the next 2 years, compared to a 24% growth forecast for the Semiconductor industry in China. Board Change • Mar 15
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 2 were independent directors. The company's board is composed of: 2 independent directors. 5 non-independent directors. Independent Director Xuhui Wen was the last independent director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity.